Pliant Therapeutics, Inc. (PLRX)

NASDAQ: PLRX · Real-Time Price · USD

1.330

+0.040 (3.10%)

At close: Mar 6, 2026, 4:00 PM EST

1.340

+0.010 (0.75%)

After-hours: Mar 6, 2026, 4:11 PM EST

Pliant Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	93.73	71.19	63.23	33.69	51.67	50.88
Short-Term Investments	148.07	284.54	431.01	297.5	148.93	226.01
Cash & Short-Term Investments	241.8	355.72	494.25	331.19	200.6	276.89
Cash Growth	-40.23%	-28.03%	49.23%	65.10%	-27.56%	169.42%
Accounts Receivable	-	-	-	1.98	2	9.28
Other Receivables	-	-	-	0.08	0.08	0.08
Total Trade Receivables	-	-	-	2.07	2.08	9.36
Other Current Assets	3.79	6.54	11.26	7.06	6.76	4.5
Total Current Assets	245.59	362.26	505.5	340.31	209.44	290.75
Net Property, Plant & Equipment	29.14	32.77	4.78	9.91	10.94	4.32
Other Long-Term Assets	1.87	1.92	1.87	0.39	0.84	0.45
Total Assets	276.6	396.95	512.15	350.61	221.22	295.53
Accounts Payable	0.49	5.96	4.53	1.58	2.97	2.02
Accrued Expenses	15.95	26.72	22.68	19.88	11.99	9.58
Current Portion of Leases	1.19	0.54	1.32	2.46	1.87	-
Total Current Liabilities	17.62	33.22	28.52	23.91	16.83	11.6
Long-Term Debt	30.44	30.21	10.05	9.93	-	-
Long-Term Leases	28.23	29.44	-	3.43	5.33	-
Other Long-Term Liabilities	-	-	-	-	-	0.87
Total Long-Term Liabilities	58.67	59.65	10.05	13.36	5.33	0.87
Total Liabilities	76.29	92.87	38.58	37.27	22.16	12.47
Common Stock	0.01	0.01	0.01	0.01	0	0
Additional Paid-in Capital	1,036	1,014	972.97	653.71	414.35	400.92
Accumulated Other Comprehensive Income	0.03	0.32	0.35	-1.96	-0.2	-0.03
Retained Earnings	-835.82	-710.05	-499.75	-338.41	-215.09	-117.83
Total Common Shareholders' Equity	200.31	304.08	473.58	313.34	199.06	283.06
Shareholders' Equity	200.31	304.08	473.58	313.34	199.06	283.06
Total Liabilities & Equity	276.6	396.95	512.15	350.61	221.22	295.53
Total Debt	59.86	60.19	11.37	15.82	7.19	0
Net Cash (Debt)	181.94	295.53	482.87	315.37	193.4	276.89
Net Cash Growth	-38.44%	-38.80%	53.11%	63.07%	-30.15%	169.42%
Net Cash Per Share	2.97	4.88	8.22	7.51	5.39	12.97
Book Value	200.31	304.08	473.58	313.34	199.06	283.06
Book Value Per Share	3.27	5.02	8.07	7.46	5.55	13.26
Tangible Book Value	200.31	304.08	473.58	313.34	199.06	283.06
Tangible Book Value Per Share	3.27	5.02	8.07	7.46	5.55	13.26

Updated Nov 6, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q